business / news / / Seeking Alpha
Lilly rises after boosting 2026 outlook and better-than-expected Q1 2026 financials.
Eli Lilly raised its full-year 2026 financial outlook above prior guidance.
KEY POINTS
- Lilly reported better-than-expected Q1 2026 financial results.
- Lilly's GLP-1 drug franchise was the main driver of its financial outperformance.
- Eli Lilly shares rose approximately 6% in premarket trading following the announcement.
COMPANIES
Summarized by Newsio from Seeking Alpha. How we summarize →